Integrated Clinical and Regulatory Support for Oncology Trials
Aurevia is a European Contract Research Organization (CRO) and regulatory partner supporting biotech, pharmaceutical, and medtech companies in the development and execution of oncology clinical research across Europe and beyond.
Oncology clinical trials are complex—scientifically, operationally, and from a regulatory perspective.
Our teams have deep knowledge with hands‑on experience, supporting oncology clinical studies across multiple indications and development phases, often in multinational and multi‑site settings.
How we support oncology programs
• Clinical study design and feasibility
• Clinical operations and monitoring
• Regulatory strategy and submissions in the EU
• Quality assurance and compliance support
Our combined clinical research and regulatory capabilities help to reduce trial risks and improve
coordination, to keep oncology programs moving forward efficiently.
Why choose Aurevia?
- Agile, mid‑sized CRO model: Flexible, responsive, and hands‑on—delivering tailored solutions rather than
one‑size‑fits‑all processes. - Local presence with broad European reach: Teams in Sweden, Germany, Poland, and Finland, with a
strong European network, to support oncology trials across multiple countries and sites. - Integrated clinical research and regulatory services: Expertise in clinical operations combined with regulatory
strategy and submissions. - Strong European regulatory specialization: Deep understanding of EU frameworks, aligning European requirements with global development strategies.
Whether you need help with designing or expanding your clinical study, developing your regulatory strategy, or full-service
support, contact us to explore how we can advance your oncology program.
BREAKING